BAY 41-2272, a Direct Activator of Soluble Guanylate Cyclase, Reduces Right Ventricular Hypertrophy and Prevents Pulmonary Vascular Remodeling during Chronic Hypoxia in Neonatal Rats (Q58351224)
Jump to navigation
Jump to search
scientific article published on 19 March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BAY 41-2272, a Direct Activator of Soluble Guanylate Cyclase, Reduces Right Ventricular Hypertrophy and Prevents Pulmonary Vascular Remodeling during Chronic Hypoxia in Neonatal Rats |
scientific article published on 19 March 2006 |
Statements
BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats (English)
Vivek Balasubramaniam
Anette M Kunig
Gregory J Seedorf
Neil E Markham
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference